Cervical cancer is among the most preventable cancers in women — yet India still accounts for nearly a quarter of cervical cancer deaths worldwide. Almost every case is caused by long-standing HPV infection, which can be prevented through vaccination and detected through simple, painless screening.
Cervical cancer occurs when cells in the cervix — the lower, narrow part of the uterus that opens into the vagina — grow uncontrollably and form a tumour. Almost all cervical cancers begin with a long-standing infection with high-risk strains of the human papillomavirus (HPV), most commonly HPV-16 and HPV-18. Over years, the virus causes changes in the cervical cells (precancerous lesions) that, if left undetected, can progress to invasive cancer.
This slow progression — typically 10 to 15 years from HPV infection to invasive cancer — is precisely what makes cervical cancer so preventable. HPV vaccination, given ideally between ages 9 and 14, can prevent the great majority of cervical cancers. Pap smears and HPV testing can detect precancerous changes years before they become cancer, and treatment at that stage is usually a simple outpatient procedure with no impact on fertility. India's growing public-health focus on HPV vaccination and cervical screening is gradually changing the trajectory of the disease.
Cervical cancers are classified by the cell type they arise from. Two main types account for almost all cases.
The most common type. It arises from the thin, flat squamous cells lining the outer part of the cervix (the ectocervix). Almost all squamous cell cervical cancers are HPV-related. Treatment is usually a combination of chemoradiation, with surgery for early-stage disease.
Arises in the glandular cells of the inner cervical canal (the endocervix) and is often harder to detect on traditional Pap smears, which is why HPV-based screening has become increasingly important. Treatment principles are similar to squamous cell cancer.
A small proportion of cervical cancers have features of both squamous and glandular cells (adenosquamous carcinoma), or are even rarer types such as small cell carcinoma, clear cell carcinoma, or sarcomas. Each requires a tailored treatment plan from a specialist gynaec-oncology team.
For detailed information on diagnosis, radical hysterectomy, chemoradiation and modern immunotherapy options, see our dedicated page on cervical cancer treatment in Hyderabad.
Early cervical cancer often produces no symptoms at all, which is why screening is so important. As the cancer grows, common signs include:
Any abnormal bleeding pattern deserves a gynaecological examination — it is rarely a serious cause, but cervical cancer must be ruled out.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
A short consultation and the right test is usually all it takes to confirm or rule out cervical cancer.
Cervical cancer remains one of the most common cancers in women across Telangana and Andhra Pradesh, and the great majority of cases are still diagnosed at advanced stages — often after months of vague bleeding or discharge dismissed as a routine gynaecological problem. Three regional realities shape the picture: low awareness of cervical cancer screening, social discomfort around discussing gynaecological symptoms, and limited uptake of HPV vaccination despite its availability in Hyderabad and most district headquarters.
The encouraging news is that government and private screening programmes — using simple visual inspection with acetic acid (VIA), Pap smears or HPV testing — are increasingly available, and treatment of precancerous lesions is straightforward, outpatient and highly effective. Any woman with abnormal bleeding, especially between periods or after intercourse, deserves a gynaecological examination without delay.
Almost all cervical cancers are caused by long-standing infection with high-risk human papillomavirus (HPV) strains. Key risk factors include:
Any of the following should prompt a gynaecological examination and specialist review:
A short specialist consultation and the right diagnostic test — imaging, colposcopy, biopsy, or blood test as appropriate — is usually enough to confirm or rule out cancer. Early action is always easier than catching up later.
Multi-disciplinary care, tumour-board review and disciplined adherence to NCCN/FIGO/ESMO protocols translate into measurable survival improvements.
*1-year survival. Source: ICMR / National Cancer Registry Programme (NCRP).
Our NABH-accredited centres across Hyderabad deliver evidence-based cervical cancer care — from Pap smear, HPV testing and colposcopy through to LEEP/cone biopsy for precancerous lesions, radical hysterectomy with pelvic lymphadenectomy, advanced external-beam radiation with brachytherapy, concurrent chemoradiation, and modern immunotherapy for advanced disease — guided by NCCN, FIGO and ESMO protocols and reviewed for every patient by a multidisciplinary gynaec-oncology tumour board.
For a detailed walk-through of cervical cancer diagnosis, treatment options, costs, and our specialist team, see our dedicated page on cervical cancer treatment in Hyderabad.
Book a free consultation at your nearest CION Cancer Clinic. Confidential, evidence-based, woman-headed care.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Early cervical cancer typically has no symptoms — which is why regular screening is so important. The most common first symptoms once cancer develops are abnormal vaginal bleeding (between periods, after intercourse, or after menopause), a persistent unusual vaginal discharge, and pelvic pain or pain during intercourse. Any abnormal bleeding pattern in a woman should be evaluated by a gynaecologist — it is rarely a serious cause, but cervical cancer must be ruled out.
Yes — long-standing infection with high-risk human papillomavirus (HPV) strains causes almost all cervical cancers. HPV-16 and HPV-18 together cause around 70% of cases. HPV is extremely common — most sexually active women will be infected at some point — and the great majority of infections clear by themselves. Only a small minority of infections persist long enough to cause precancerous changes and, eventually, cancer. HPV vaccination prevents the great majority of cervical cancers when given before exposure.
Yes — cervical cancer is highly curable when caught early. Precancerous changes detected through screening are cured with simple outpatient procedures and rarely affect fertility. Early invasive cervical cancer (Stage I) has 5-year survival rates above 90%. Even locally advanced cervical cancer can often be cured with a combination of chemotherapy and radiation, with cure rates of 50–65%. The earlier the diagnosis, the simpler the treatment and the better the outcome.
HPV vaccination is recommended for all girls between the ages of 9 and 14 — ideally before any HPV exposure. The vaccine is also useful up to age 26, and can be considered up to age 45 for women not previously vaccinated. Boys also benefit from HPV vaccination because the same virus causes anal, penile and oropharyngeal cancers. The vaccine is now widely available across Hyderabad and is one of the most effective cancer prevention tools we have. Speak to your doctor about whether it is right for you or your child.
Cervical screening is recommended for all women starting at age 21. Pap smear every 3 years from 21 to 29, then Pap smear plus HPV co-testing every 5 years (or HPV testing alone every 5 years) from 30 to 65. Women with abnormal results, a history of cervical pre-cancer, or HIV infection need more frequent screening. Most women can stop screening at 65 if they have had consistently normal results. A specialist can advise on the right screening interval for you.
Disclaimer: This page is intended for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified oncologist for guidance specific to your medical condition. Content on this page is periodically reviewed and updated by CION's medical team in accordance with current clinical guidelines.
